{"entity":{"type":"insider","cik":"0001410397","url":"/insider/0001410397","json_url":"/insider/0001410397.json","name":"Grant Stuart","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":11,"first":"2008-08-04","last":"2011-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Grant Stuart","source":"filing","n_filings":11,"first_seen":"2008-08-04","last_seen":"2011-03-18"}],"transactions":[{"id":8994757,"accession":"0001127602-11-010722","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-11-010722","line_url":"/filing/0001127602-11-010722","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22615.0,"shares_display":"22,615","price_per_share":3.392653106345346,"price_display":"3.39","price_state":"stated","total_value":76724.85,"total_display":"76,724.85","total_whole":"76,725","shares_owned_after":14717.0,"shares_owned_after_display":"14,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-16","filed_date":"2011-03-18","scope":"insider","n_lines":2},{"id":7237722,"accession":"0001127602-10-020812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-10-020812","line_url":"/filing/0001127602-10-020812#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":6.2,"price_display":"6.20","price_state":"stated","total_value":15500.0,"total_display":"15,500.00","total_whole":"15,500","shares_owned_after":11717.0,"shares_owned_after_display":"11,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-04","filed_date":"2010-08-06","scope":"insider"},{"id":7194174,"accession":"0001127602-10-016469","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-10-016469","line_url":"/filing/0001127602-10-016469#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":6.97,"price_display":"6.97","price_state":"stated","total_value":8712.5,"total_display":"8,712.50","total_whole":"8,713","shares_owned_after":11717.0,"shares_owned_after_display":"11,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-03","filed_date":"2010-06-04","scope":"insider"},{"id":7255499,"accession":"0001127602-10-013184","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-10-013184","line_url":"/filing/0001127602-10-013184#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":7.68,"price_display":"7.68","price_state":"stated","total_value":9600.0,"total_display":"9,600.00","total_whole":"9,600","shares_owned_after":11717.0,"shares_owned_after_display":"11,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-03","filed_date":"2010-05-05","scope":"insider"},{"id":7212490,"accession":"0001127602-10-012584","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-10-012584","line_url":"/filing/0001127602-10-012584#line-4","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36990.0,"shares_display":"36,990","price_per_share":8.31,"price_display":"8.31","price_state":"stated","total_value":307386.9,"total_display":"307,386.90","total_whole":"307,387","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-29","filed_date":"2010-04-30","scope":"insider"},{"id":7212486,"accession":"0001127602-10-012584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-10-012584","line_url":"/filing/0001127602-10-012584#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1563.0,"shares_display":"1,563","price_per_share":8.26,"price_display":"8.26","price_state":"stated","total_value":12910.38,"total_display":"12,910.38","total_whole":"12,910","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-28","filed_date":"2010-04-30","scope":"insider"},{"id":7255347,"accession":"0001127602-10-011087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-10-011087","line_url":"/filing/0001127602-10-011087#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":509.0,"shares_display":"509","price_per_share":8.26,"price_display":"8.26","price_state":"stated","total_value":4204.34,"total_display":"4,204.34","total_whole":"4,204","shares_owned_after":11717.0,"shares_owned_after_display":"11,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-12","filed_date":"2010-04-14","scope":"insider"},{"id":7340650,"accession":"0001127602-10-010660","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-10-010660","line_url":"/filing/0001127602-10-010660","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1249.0,"shares_display":"1,249","price_per_share":6.9601040832666135,"price_display":"6.96","price_state":"stated","total_value":8693.17,"total_display":"8,693.17","total_whole":"8,693","shares_owned_after":11730.0,"shares_owned_after_display":"11,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-05","filed_date":"2010-04-06","scope":"insider","n_lines":2},{"id":7545685,"accession":"0001127602-10-007575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-10-007575","line_url":"/filing/0001127602-10-007575#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":6.958,"price_display":"6.96","price_state":"stated","total_value":104370.0,"total_display":"104,370.00","total_whole":"104,370","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-03","filed_date":"2010-03-04","scope":"insider"},{"id":7449517,"accession":"0001127602-10-002100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-10-002100","line_url":"/filing/0001127602-10-002100#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17027.0,"shares_display":"17,027","price_per_share":7.02,"price_display":"7.02","price_state":"stated","total_value":119529.54,"total_display":"119,529.54","total_whole":"119,530","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-22","filed_date":"2010-01-25","scope":"insider"},{"id":5616329,"accession":"0001127602-09-002350","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-09-002350","line_url":"/filing/0001127602-09-002350#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.615,"price_display":"1.62","price_state":"stated","total_value":4845.0,"total_display":"4,845.00","total_whole":"4,845","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-30","filed_date":"2009-02-03","scope":"insider"},{"id":3897270,"accession":"0000882796-08-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000882796-08-000033","line_url":"/filing/0000882796-08-000033#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001410397","owner_name":"Grant Stuart","owner_display_name":"Grant Stuart","owner_url":"/insider/0001410397","role":"Officer (SR VP & CFO)","role_mark":"O","role_mark_label":"Officer (SR VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.822,"price_display":"2.82","price_state":"stated","total_value":8466.0,"total_display":"8,466.00","total_whole":"8,466","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-04","filed_date":"2008-08-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Officer (SR VP & CFO)","n_filings":11,"first_seen":"2008-08-04","last_seen":"2011-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001410397","retrieved_at":"2026-08-25T18:45:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}